Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines

被引：0
作者：
Christina Karner
Ines Anders
Djenana Vejzovic
Joanna Szkandera
Susanne Scheipl
Alexander J. A. Deutsch
Larissa Weiss
Klemens Vierlinger
Dagmar Kolb
Stefan Kühberger
Ellen Heitzer
Hansjörg Habisch
Fangrong Zhang
Tobias Madl
Birgit Reininger-Gutmann
Bernadette Liegl-Atzwanger
Beate Rinner
机构：
[1] Medical University of Graz,Division of Biomedical Research, Core Facility Alternative Biomodels and Preclinical Imaging
[2] Medical University of Graz,Division of Oncology, Department of Internal Medicine
[3] Medical University of Graz,Department of Orthopedics and Trauma
[4] Medical University of Graz,Division of Hematology
[5] University of Technology,Institute for Health Care Engineering With European Testing Center of Medical Devices
[6] AIT Austrian Institute of Technology GmbH,Competence Unit Molecular Diagnostics, Center for Health and Bioresources
[7] Medical University of Graz,Core Facility Ultrastructure Analysis, Center for Medical Research, Gottfried Schatz Research Center
[8] Medical University of Graz,Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center
[9] Medical University of Graz,Diagnostic and Research Institute of Human Genetics, Diagnostic and Research Center for Molecular Biomedicine
[10] Medical University of Graz,Research Unit Integrative Structural Biology, Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Molecular Biology and Biochemistry
[11] Fujian Medical University,Key Laboratory of Ministry of Education of Gastrointestinal Cancer
[12] Medical University of Graz,Diagnostic and Research Institute of Pathology
[13] BioTechMed-Graz,undefined
来源：
Journal of Translational Medicine | / 21卷
关键词：
Clear cell sarcoma; Metastases; Epigenetic hall marks; Arginine methylation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 214 条
  • [1] Ibrahim RM(2018)Clear cell sarcoma-a review J Orthop 15 963-966
  • [2] Steenstrup Jensen S(1999)Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 30 cases Cancer 86 969-975
  • [3] Juel J(2007)Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients Cancer 109 109-116
  • [4] Deenik W(1983)Malignant melanoma of soft parts. A reassessment of clear cell sarcoma Am J Surg Pathol 7 405-13
  • [5] Mooi WJ(2020)Molecular principles of metastasis: a hallmark of cancer revisited Signal Transduct Target Ther 5 28-460
  • [6] Rutgers EJ(2008)Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 Cases Am J Surg Pathol 32 452-iv67
  • [7] Peterse JL(2018)Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 29 iv51-189
  • [8] Hart AA(2013)Targeting histone modifications–epigenetics in cancer Curr Opin Cell Biol 25 184-5403
  • [9] Kroon BB(2021)Protein arginine methyltransferase (PRMT) inhibitors-AMI-1 and SAH are effective in attenuating rhabdomyosarcoma growth and proliferation in cell cultures Int J Mol Sci 22 8023-898
  • [10] Kawai A(2021)PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma Theranostics 11 5387-13
12345678910